336.76USD+2.92%Mkt Cap: —P/E: 15.481d ago
Labcorp Holdings Inc. provides laboratory services. It operates in Diagnostics Laboratories and Biopharma Laboratory Services segments. The company offers various tests, such as blood chemistry analyses, urinalyses, bloo…
Industry Peers
Biotechnology$139.84BUSDP/E 32.2
$85.11BUSDP/E 20.4
$69.62BUSD
$60.19BUSDP/E 39.1
$45.16BUSDP/E 19.2
$46.01BUSD
$41.76BUSDP/E 66.2
$35.67BUSDP/E 33.2
$32.46BUSDP/E 42.3
$28.53BUSD
$26.14BUSD
$25.79BUSDP/E 16.2
$20.83BUSDP/E 26.3
$19.17BUSDP/E 26.2
$17.03BUSDP/E 20.0
$16.41BUSD
$13.48BUSDP/E 17.1
$13.42BUSDP/E 187.4
$12.87BUSDP/E 264.5
$12.59BUSD
Key Statistics
Company
Market Cap—
Enterprise Value34.04B $
Revenue (TTM)14.35B $
Gross Profit4.14B $
Net Income (TTM)1.00B $
Revenue/Share174.02 USD
Last Price336.76 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees71.0K
CountryGB
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)15.48
P/E (Forward)—
PEG—
EV/EBITDA14.68
EV/Revenue2.37
P/S—
P/B3.14
EPS (TTM)21.78
EPS (Forward)—
52W Range
319.1485% of range339.92
52W High339.92 USD
52W Low319.14 USD
Profitability
Gross Margin28.88%
Oper. Margin12.24%
EBITDA Margin16.17%
Profit Margin6.99%
ROE11.73%
ROA5.53%
Growth
Revenue Growth5.80%
Earnings Growth28.20%
Cash Flow & Leverage
Operating CF1.64B $
CapEx (TTM)—
FCF Margin6.22%
FCF Yield—
Net Debt6.68B $
Net Debt/EBITDA2.88
Balance Sheet
Debt/Equity79.12
Current Ratio1.80
Quick Ratio1.25
Book Value/Sh106.39 USD
Cash/Share1.748 USD
Dividends
Fwd Div Rate—
Trail. Div Rate2.880 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.100.90M
Float80.71M
Insiders0.35%
Institutions102.42%
Technical
SMA 50221.92 (+51.7%)
SMA 200215.45 (+56.3%)
Beta0.84
S&P 52W Chg18.16%
Avg Vol (30d)36
Avg Vol (10d)254
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—